JD.com Inc. (NASDAQ:JD) is one of the best NASDAQ stocks under $30 to buy. On March 16, Reuters reported that JD.com officially launched its Joybuy online marketplace in the UK, Germany, France, the ...

Joybuy launched in the UK in March and is an online shopping platform owned by China's biggest retailer JD.com, so it has strong backing. Like Amazon, it sells big brands and offers speedy same or ...

Liftoff occurred at 4:57 a.m. EDT on Thursday (April 30). When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Europe's most powerful rocket roared ...

The major global ecommerce player is expanding into Britain with big ambitions 🛒 Chinese ecommerce giant JD.com has launched its Joybuy shopping platform in the UK for the first time The site ...

A United Launch Alliance Atlas V rocket launched 29 of Amazon's internet satellites on Monday night (April 27), tying its payload-weight record in the process. The Atlas V lifted off from Florida's ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Kia is bringing the next-generation Kia Seltos to Europe for the first time, marking a ...

Amazon One Medical launched a GLP-1 program integrating obesity care with Amazon Pharmacy. Pricing for the popular weight loss drugs will begin at as low as $25 per month with insurance. Shares of ...

SolarEdge Technologies (SEDG) up 3.5% in early trading Tuesday after saying it launched a new commercial storage system for the European and Asian markets, reaching up to 197 kWh for medium- to ...

Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in. The Seattle-based tech giant launched its own GLP-1 program aimed at streamlining access to weight loss drugs, with ...

An Ariane 64 lifts off April 30 carrying a second set of Amazon Leo satellites. Credit: ESA-CNES-Arianespace-ArianeGroup/Optique Vidéo du CSG - S. Martin WASHINGTON — A pair of launches this week has ...

Roche, Sanofi plan Europe drug launches despite hurdles Roche CEO: EU bureaucracy and low prices threaten innovation Roche joins AstraZeneca in highlighting risks for Europe Experts say Europe remains ...